Groundbreaking Nobel in Medicine; Strategic Healthcare Expansions
Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi won the Nobel Prize for pioneering research in immune system functions. Qualtrics acquires healthcare firm Press Ganey for $6.75 billion. Eli Lilly plans over $1 billion investment in India to enhance manufacturing and increase drug availability, focusing on conditions like diabetes and cancer.

In a notable achievement for immunological research, American scientists Mary Brunkow and Fred Ramsdell, alongside Japanese researcher Shimon Sakaguchi, have been awarded the 2025 Nobel Prize in Physiology or Medicine. Their valuable work illuminates the mechanisms by which the immune system distinguishes between harmful invaders and healthy cells, paving the way for innovative autoimmune disease and cancer treatments.
Meanwhile, the acquisition landscape in the healthcare sector sees a significant shift as Qualtrics, under the ownership of Silver Lake, secures a deal to purchase market research company Press Ganey for $6.75 billion. The strategic move aims to blend Qualtrics' artificial intelligence capabilities with Press Ganey's healthcare reach, heralding the creation of pioneering AI-driven healthcare tools.
Pharmaceutical giant Eli Lilly has announced a substantial investment exceeding $1 billion in India. This investment is part of Lilly's broader strategy to enhance its global manufacturing capacity and ensure a steady supply of its critical drugs, particularly in areas such as obesity, diabetes, Alzheimer's, cancer, and autoimmune disorders.
ALSO READ
Eli Lilly's Billion-Dollar Bet on Hyderabad: A Transformative Boost for Global Medicine Access and Local Economy
US pharma major Eli Lilly to invest USD 1 billion in Telangana.
Eli Lilly's $1 Billion Bet on Telangana: A Pharma Giant's Expansion Unveiled
Eli Lilly to Invest $1 Billion in India, Establish New Hyderabad Hub
Eli Lilly's $1 Billion Lifeline: Transforming Telangana's Pharma Landscape